Patents by Inventor Vassil St. Georgiev

Vassil St. Georgiev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050026910
    Abstract: The present invention relates to novel chemical compounds, methods for their discovery, and therapeutic use. In particular, the present invention provides benzimidazole derivatives and methods of using benzimidazole derivatives as therapeutic agents to treat a number of conditions associated with retroviral infection.
    Type: Application
    Filed: June 28, 2004
    Publication date: February 3, 2005
    Applicant: The Regents of the University of Michigan
    Inventors: William Roush, Nan Zheng, Vassil St. Georgiev
  • Patent number: 4803282
    Abstract: .alpha.-Substituted ketonitrone derivatives containing substitutents selected from hydrogen, phenyl, substituted phenyl, naphythyl, furan, thiopen, imidazolylmethyl and triazolylmethyl are useful as intermediates for the preparation of biologically active isoxazolidine compounds.
    Type: Grant
    Filed: August 27, 1986
    Date of Patent: February 7, 1989
    Assignee: Pennwalt Corporation
    Inventors: Vassil St. Georgiev, George B. Mullen
  • Patent number: 4727156
    Abstract: 3-(Substituting phenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-{[(substituted phenyl)thio]m ethyl}isoxazolidines in which hydrogens of their phenyl rings may be replaced by halogen, lower alkoxy, lower alkyl or nitro groups, and the sulfur atom may be oxidized, are useful as antifungal agents.
    Type: Grant
    Filed: August 27, 1986
    Date of Patent: February 23, 1988
    Assignee: Pennwalt Corporation
    Inventors: Vassil St. Georgiev, George B. Mullen
  • Patent number: 4727157
    Abstract: 3-(substituted phenyl)-3-(1H-1,2,4-triazol-1-yl)methyl-2-methyl-5-[(substituted phenoxy)methyl]isoxazolidine derivatives in which hydrogens of their phenyl rings may be replaced by halogen, lower alkyl, lower alkoxy, alkoxycarbonyl, alkanoylamino or nitro groups are useful as antifungal agents.
    Type: Grant
    Filed: August 27, 1986
    Date of Patent: February 23, 1988
    Assignee: Pennwalt Corporation
    Inventors: Vassil St. Georgiev, George B. Mullen
  • Patent number: 4723021
    Abstract: Substituted 5-(phenoxyalkyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine s, in which hydrogens of their benzene rings may be replaced by halogen, lower alkoxy, lower alkyl, nitro, acetamido and/or trifluoromethyl groups, are useful as antifungal agents.
    Type: Grant
    Filed: August 27, 1986
    Date of Patent: February 2, 1988
    Assignee: Pennwalt Corporation
    Inventors: Vassil St. Georgiev, George B. Mullen
  • Patent number: 4719306
    Abstract: Substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines in which hydrogens of their phenyl rings may be replaced by halogen, lower alkoxy or lower alkyl groups are useful as antifungal agents.
    Type: Grant
    Filed: August 27, 1986
    Date of Patent: January 12, 1988
    Assignee: Pennwalt Corporation
    Inventors: Vassil St. Georgiev, George B. Mullen
  • Patent number: 4668678
    Abstract: New triazoloquinoxalin-1,4-diones are described as well as the use thereof as anti-allergenic agents.
    Type: Grant
    Filed: February 22, 1985
    Date of Patent: May 26, 1987
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vassil St. Georgiev, Philip Kropp, Bernard Loev
  • Patent number: 4507300
    Abstract: New triazoloquinoxalin-1,4-diones are described as well as the use thereof as anti-allergenic agents.
    Type: Grant
    Filed: June 6, 1983
    Date of Patent: March 26, 1985
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vassil St. Georgiev, Philip Kropp, Bernard Loev
  • Patent number: 4486601
    Abstract: Esters of 2-adamantanone oxime are prepared and are disclosed as possessing anti-inflammatory activity and antiviral activity against murine hepatitis virus.
    Type: Grant
    Filed: August 19, 1983
    Date of Patent: December 4, 1984
    Assignee: Pennwalt Corporation
    Inventors: C. Richard Kinsolving, Vassil St. Georgiev
  • Patent number: 4405633
    Abstract: Provided is a method of treating asthma. The method is the administering to a patient requiring treatment of an effective dose of a benzoxazole-2-carboxylic acid or an ester or therapeutically-acceptable salt of benzoxazole-2-carboxylic acid.
    Type: Grant
    Filed: March 1, 1982
    Date of Patent: September 20, 1983
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Bernard Loev, Vassil St. Georgiev
  • Patent number: 4400382
    Abstract: New triazoloquinoxalin-1,4-diones are described as well as the use thereof as anti-allergenic agents.
    Type: Grant
    Filed: March 16, 1981
    Date of Patent: August 23, 1983
    Assignee: USV Pharmaceutical Corporation
    Inventors: Richard E. Brown, Vassil St. Georgiev, Philip Kropp, Bernard Loev
  • Patent number: 4354027
    Abstract: New substituted triazoloquinoxalin-4-ones are described as well as the use thereof as anti-hypertensive agents.
    Type: Grant
    Filed: May 19, 1980
    Date of Patent: October 12, 1982
    Assignee: USV Pharmaceutical Corporation
    Inventors: Bernard Loev, John T. Suh, Bruce E. Williams, Vassil St. Georgiev